MK
Murali Krishna Kodali
About Murali Krishna Kodali
Data last updated:
Murali Krishna Kodali is a Director at Helixcell Therapeutics Private Limited (since 2023). The company operates in Professional Services. Helixcell Therapeutics Private Limited reported revenue of ₹1.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Helixcell Therapeutics Private Limited U72100TS2023PTC178764 | Director | 06 Nov 2023 | 2023 | ₹1.3 Lakh (FY 2025) | Active |
Board colleagues of Murali Krishna Kodali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lavanya Kodali | 10778061 | Helixcell Therapeutics Private Limited | Director |
| Rama Krishna Kodali | 10382705 | Helixcell Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murali Krishna Kodali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murali Krishna Kodali
Murali Krishna Kodali currently holds 1 directorship: Helixcell Therapeutics Private Limited (Director, since 06 Nov 2023, revenue ₹1.3 Lakh (FY 2025)).
Murali Krishna Kodali was first appointed on 06 Nov 2023 as Director at Helixcell Therapeutics Private Limited.
The current boards of Murali Krishna Kodali's companies include Lavanya Kodali (Helixcell Therapeutics Private Limited), Rama Krishna Kodali (Helixcell Therapeutics Private Limited).